Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer's disease.
Charou D, Rogdakis T, Latorrata A, Valcarcel M, Papadogiannis V, Athanasiou C, Tsengenes A, Papadopoulou MA, Lypitkas D, Lavigne MD, Katsila T, Wade RC, Cader MZ, Calogeropoulou T, Gravanis A, Charalampopoulos I.
Charou D, et al. Among authors: athanasiou c.
Stem Cell Res Ther. 2024 Jul 6;15(1):200. doi: 10.1186/s13287-024-03818-w.
Stem Cell Res Ther. 2024.
PMID: 38971770
Free PMC article.